Literature DB >> 29786483

Immediate Mild Reactions to CT with Iodinated Contrast Media: Strategy of Contrast Media Readministration without Corticosteroids.

Sae-Jin Park1, Dong-Yoon Kang1, Kyoung-Hee Sohn1, Soon-Ho Yoon1, Whal Lee1, Young-Hun Choi1, Sang Heon Cho1, Hye-Ryun Kang1.   

Abstract

Purpose To evaluate premedication protocols involving administration of antihistamine and multidose corticosteroid that have been widely used in prevention of recurrent hypersensitivity reactions (HSRs) to iodinated contrast media (ICM); an evidence-based optimal preventive strategy customized for patients with mild cases has not yet been established. Materials and Methods The outcomes of patients with mild HSR who subsequently underwent contrast material-enhanced computed tomography (CT) between January 2012 and December 2015 were analyzed. For premedication, 4 mg of chlorpheniramine was intravenously administered 30 minutes prior to reexposure to ICM. Logistic regression with generalized estimating equations was used to determine the relationship between premedication and recurrence rate. Results A total of 1178 patients with mild immediate HSR were reexposed to ICM 3533 times. Among these patients, 1056 patients experienced allergylike reactions and 122 patients developed gastrointestinal reactions. With reexposure to the culprit agent without premedication, the recurrence rate was 31.1% (85 of 273 examinations). The recurrence rate decreased to 12% (105 of 872 examinations; P < .001) by only changing the culprit agent and to 7.6% (148 of 1947 examinations; P < .001) by using the combination of changing the ICM and antihistamine premedication. Changing the ICM plus antihistamine premedication was also helpful in reducing the recurrence of gastrointestinal symptoms from 16.1% to 1.8% (P = .020). However, despite changing of the ICM, some combinations of ICM did not show a prophylactic effect. Conclusion A combination of changing the culprit agent and antihistamine premedication resulted in the best preventive outcome for patients with mild immediate HSR. The optimal choice of substitute ICM could be individualized according to the culprit agent. © RSNA, 2018 Online supplemental material is available for this article .

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29786483     DOI: 10.1148/radiol.2018172524

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

1.  Reduced iodinated contrast media dose and injection speed for CT: how much does this decrease the risk of a hypersensitivity reactions?

Authors:  Knut Brockow
Journal:  Quant Imaging Med Surg       Date:  2020-02

Review 2.  Updated guidelines for intravenous contrast use for CT and MRI.

Authors:  Kevin Huynh; Arthur H Baghdanian; Armonde A Baghdanian; Derek S Sun; K Pallav Kolli; Ronald J Zagoria
Journal:  Emerg Radiol       Date:  2020-01-10

3.  A Comparison of Biannual Two-Phase Low-Dose Liver CT and US for HCC Surveillance in a Group at High Risk of HCC Development.

Authors:  Jeong Hee Yoon; Jeong Min Lee; Dong Ho Lee; Ijin Joo; Ju Hyun Jeon; Su Joa Ahn; Seung-Taek Kim; Eun Ju Cho; Jeong-Hoon Lee; Su Jong Yu; Yoon Jun Kim; Jung-Hwan Yoon
Journal:  Liver Cancer       Date:  2020-08-06       Impact factor: 11.740

Review 4.  Diagnosis and Prevention of Hypersensitivity Reactions to Iodinated Contrast Media.

Authors:  Hye-Ryun Kang; Jiung Jeong; Knut Brockow
Journal:  Allergy Asthma Immunol Res       Date:  2022-07       Impact factor: 5.096

Review 5.  Hypersensitivity Reactions to Iodinated Contrast Media.

Authors:  Tsu-Man Chiu; Sung-Yu Chu
Journal:  Biomedicines       Date:  2022-04-30

6.  Risk of Hypersensitivity Reactions to Iopromide After Intra-Arterial Versus Intravenous Administration: A Nested Case-Control Analysis of 133,331 Patients.

Authors:  Jan Endrikat; Alexander Michel; Ralf Kölbach; Philipp Lengsfeld; Kai Vogtländer
Journal:  Invest Radiol       Date:  2020-01       Impact factor: 10.065

7.  Change the preprocedural fasting policy for contrast-enhanced CT: results of 127,200 cases.

Authors:  Heng Liu; Li Zhao; Junling Liu; Fang Lan; Li Cai; Jingqin Fang; Xue Li
Journal:  Insights Imaging       Date:  2022-02-24

8.  Risk of Hypersensitivity Reactions to Iopromide in Children and Elderly: An Analysis of 132,850 Patients From 4 Observational Studies and Pharmacovigilance Covering >288 Million Administrations.

Authors:  Jan Endrikat; Julia Chernova; Christoph Gerlinger; Marcin Pracz; Philipp Lengsfeld; Aasia Bhatti; Alexander Michel
Journal:  Invest Radiol       Date:  2022-05-01       Impact factor: 6.016

Review 9.  Pharmacological Prevention of Hypersensitivity Reactions Caused by Iodinated Contrast Media: A Systematic Review and Meta-Analysis.

Authors:  Chen Hsieh; Shan Chia Wu; Russell Oliver Kosik; Yu-Chen Huang; Wing P Chan
Journal:  Diagnostics (Basel)       Date:  2022-07-09

Review 10.  Drug hypersensitivity reactions in Asia: regional issues and challenges.

Authors:  Bernard Yu-Hor Thong; Michaela Lucas; Hye-Ryun Kang; Yoon-Seok Chang; Philip Hei Li; Min Moon Tang; James Yun; Jie Shen Fok; Byung-Keun Kim; Mizuho Nagao; Iris Rengganis; Yi-Giien Tsai; Wen-Hung Chung; Masao Yamaguchi; Ticha Rerkpattanapipat; Wasu Kamchaisatian; Ting Fan Leung; Ho Joo Yoon; Luo Zhang; Amir Hamzah Abdul Latiff; Takao Fujisawa; Francis Thien; Mariana C Castells; Pascal Demoly; Jiu-Yao Wang; Ruby Pawankar
Journal:  Asia Pac Allergy       Date:  2020-01-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.